Handelsavisen
prelaunch
Companies Financials AFJK.O
AF
AFJK.O NASDAQ Investment Holding Companies

Aimei Health Technology Co Ltd

$12,12
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
38,4M USD
P/E
120,1x
EV / Rev
Div yield
Op margin
ROE
1,1 %
Net margin
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
$40,00
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Aimei Health Technology Co Ltd is an investment holding company that operates primarily in the financial sector, managing a portfolio of investments and generating income through equity stakes and asset management.

Business. Aimei Health Technology Co Ltd (AFJK.O) is an investment holding company listed on the NASDAQ. The firm operates within the Financials sector, specifically classified under Investment Holding Companies. Detailed information regarding its operating segments, headquarters location, and geographic revenue mix is not available. Consequently, the company is described at the industry level as an entity engaged in investment holding activities.

Classification92 %
SectorFinancials
Business sectorInvestment Holding Companies
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
120,1x
P/E
Analysts
not yet wired
Ownership
JPMorgan Private Bank (United States)
largest disclosed fund holder
Profitability
1,1 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning AFJK.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to AFJK.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Aimei Health Technology Co Ltd (AFJK.O) is an investment holding company listed on the NASDAQ. The firm operates within the Financials sector, specifically classified under Investment Holding Companies. Detailed information regarding its operating segments, headquarters location, and geographic revenue mix is not available. Consequently, the company is described at the industry level as an entity engaged in investment holding activities.

    Classification92 %
    SectorFinancials
    Business sectorInvestment Holding Companies
    AI synthesis
    GENERATED

    Aimei Health Technology Co Ltd maintains a strong liquidity position, as evidenced by a current ratio of 6.13, indicating that the company has significantly more current assets than current liabilities. The company's total equity of $70.5 million is supported by total assets of $71.3 million, with no long-term debt, suggesting a conservative capital structure. The price-to-book ratio of 1.81 and price-to-tangible-book ratio of 1.81 indicate that the company's market value is slightly above its book value, which is in line with the industry norms for investment holding companies.

    In terms of profitability, the company reported a net income of $755,500 despite an operating loss of $153,630, which suggests that non-operating income or gains may have contributed to the bottom line. The return on equity (ROE) of 1.07% and return on assets (ROA) of 1.06% are below the industry median for investment holding companies, indicating that the company is not generating strong returns relative to its equity and asset base.

    The company's revenue is not disclosed in the provided data, and no specific segments or geographic regions are identified. However, the absence of detailed segment reporting is common for investment holding companies, which typically consolidate their operations under a single reporting line. The company's exposure to geographic and segment-specific risks is therefore not quantifiable from the available data.

    Looking ahead, the company's growth trajectory is not clearly defined in the provided data. The absence of forward-looking guidance and the lack of historical revenue data make it difficult to assess the company's growth potential. However, the company's strong liquidity position and low debt-to-equity ratio of 0 suggest that it is well-positioned to pursue new investment opportunities or weather economic downturns.

    The risk assessment indicates that the company faces low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt load and strong equity position reduce the likelihood of financial distress. However, the company's reliance on investment income exposes it to market volatility and the performance of its underlying assets. No dilution risks are currently flagged, and the company's share count has not changed between basic and diluted shares, indicating no imminent pressure from share issuance.

    No recent events, such as filings or transcripts, are provided in the data to indicate any material changes in the company's operations or strategy. The company's financial performance and risk profile appear to be stable, with no immediate red flags or significant developments reported in the available data.

    Key takeaways
    • Aimei Health Technology Co Ltd is an investment holding company with a strong liquidity position and no long-term debt.
    • The company's ROE and ROA are below the industry median, indicating suboptimal returns on equity and assets.
    • The company's capital structure is conservative, with a current ratio of 6.13 and a debt-to-equity ratio of 0.
    • The company's growth trajectory is unclear due to the lack of historical revenue data and forward-looking guidance.
    • The company faces low liquidity and dilution risks, with no immediate filing-based flags detected.
    • The company's exposure to geographic and segment-specific risks is not quantifiable from the available data.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation FY

    Market price
    $12,12
    Market cap
    $127.3M
    Enterprise value
    P/E
    120.1x
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    1.8x
    P / Tangible book
    1.8x
    Tangible book
    $70.5M
    Net cash
    Current ratio
    6.1
    Debt / equity
    0.0
    ROA
    1.1%
    ROE
    1.1%
    Cash conversion
    -22.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    ROE1,1 %Below median
    D/E0,00Above median
    Cash Conv-0,22Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • Aimei Health Technology Co Ltd Market data — financials · 2026-05-27

    Ownership & reference

    Top holders

    • JPMorgan Private Bank (United States)Investment Managers · as of 2026-03-310,02 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    — missing data

    Short positioning

    4.4Kshares short+3.5% vs prior
    1days to cover
    25.4%short of daily vol
    1.3Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    AFJK.OCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 15.9%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -174.9%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 169.5%Derived (calculated)
    • Return on equity (FY 2025-12-31): -26.1%Derived (calculated)
    • Current ratio (FY 2025-12-31): 0.00xDerived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): 21.5%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): -83.6%Derived (calculated)
    • Return on assets (FY 2025-12-31): 8.8%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): -1.00xDerived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): -58.5%Derived (calculated)
    • Operating cash flow (annual): USD -565.1KSEC XBRL filing
    • Total assets (annual): USD 12.1MSEC XBRL filing
    • Shares outstanding (annual): 2.13MSEC XBRL filing
    • Shareholders' equity (annual): USD -4.06MSEC XBRL filing
    • Total liabilities (annual): USD 4.06MSEC XBRL filing
    • Current assets (annual): USD 2.93KSEC XBRL filing
    • Current liabilities (annual): USD 3.37MSEC XBRL filing
    • Operating income (annual): USD -835.76KSEC XBRL filing
    • Net income (annual): USD 1.06MSEC XBRL filing
    • Shareholders' equity (YoY) (2024-12-31 vs 2023-12-31): -1,000.9%Derived (calculated)
    • Return on assets (FY 2024-12-31): 3.5%Derived (calculated)
    • Return on equity (FY 2024-12-31): -172.8%Derived (calculated)
    • Current ratio (FY 2024-12-31): 0.04xDerived (calculated)
    • Debt-to-equity (FY 2024-12-31): -1.02xDerived (calculated)
    Showing 24 of 41 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-06-17 00:00 UTCTRANSCRIPTEarnings call — Q2 2026
    2026-06-17 00:00 UTCEARNINGSUpcomingEarnings scheduled →
    2026-06-17EVENTQ2 2026 earnings (expected) estimated date
    2026-06-16FILING10-Q filing →
    2026-06-04FILING8-K filing →
    2026-05-20FILING8-K filing →
    2026-05-06FILING8-K filing →
    2026-05-04FILING10-K filing →
    2026-04-21FILING8-K filing →
    2026-04-07FILING8-K filing →
    2026-03-04FILING8-K filing →
    2026-02-13FILING8-K filing →
    2026-01-06FILING8-K filing →
    2025-12-08FILING8-K filing →
    2025-12-02FILING8-K filing →
    2025-02-11 00:00 UTCINSIDER1 insider transaction — 2025-02 · net sell $1.6M
    2023-12-01 00:00 UTCINSIDER2 insider transactions — 2023-12 · net buy $3.3M 1 derivative
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage